Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives

Circulating tumor DNA (ctDNA) is cell-free DNA (cfDNA) fragment in the bloodstream that originates from malignant tumors or circulating tumor cells. Recently, ctDNA has emerged as a promising non-invasive biomarker in clinical oncology. Analysis of ctDNA opens up new avenues for individualized cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yan, Mei, Wuxuan, Ma, Kaidong, Zeng, Changchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637327/
https://www.ncbi.nlm.nih.gov/pubmed/34868984
http://dx.doi.org/10.3389/fonc.2021.763790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637327/
https://www.ncbi.nlm.nih.gov/pubmed/34868984
http://dx.doi.org/10.3389/fonc.2021.763790

Ejemplares similares